Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer-Reference-Cited by-同舟云学术

Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer

Published:2020-03 Issue:3 Volume:61 Page:375-396
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Donohoe Kevin J.,Aloff Jennifer,Avram Anca M.,Bennet K.G.,Giovanella Luca,Greenspan Bennett,Gulec Seza,Hassan Aamna,Kloos Richard T.,Solórzano Carmen C.,Stack Brendan C.,Tulchinsky Mark,Tuttle Robert Michael,Van Nostrand Douglas,Wexler Jason A.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference145 articles.

1. Radioiodine and thyroid disease: the beginning

2. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease*1

3. Protecting Access to Medicare Act of 2014, Pub L No. 113-93, 128 Stat 1040 (2014).

4. Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement?

5. Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiated Thyroid Cancer after Thyroidectomy;RadioGraphics;2024-10-01

2. Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer;Current Oncology;2024-07-03

3. Study of Simultaneous Counting of Thyroid Uptake with Quantitative Analysis of Thyroid Scans;Journal of Radiological Science and Technology;2023-10-30

4. Nuclear Imaging and Therapy of Thyroid Disorders;Molecular Imaging and Therapy;2023-10-04

5. Actualización en carcinoma diferenciado de tiroides refractario a radioyodo;Revista Española de Medicina Nuclear e Imagen Molecular;2023-09